The Impact of Radiation on Serum Anti-Mullerian Hormone during Hysterosalpingography

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210329005

Enrollment

Registered

2021-03-29

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian reserve evaluating by serum anti-mullerian hormone in infertile women requiring hysterosalpingography AMH, Anti-Mullerian hormone, hysterosalpingography, ovarian reserve, radiation

Interventions

Thai women aged 25-40 years diagnosed with infertility requiring hysterosalpingography as initial investigation ,Healthy volunteer women aged 25-40 years (Age-matching)

Diagnostic,Diagnostic

Infertile women (Case),Healthy volunteer women (Control group)

Eligibility

Sex/Gender

Female

Age

25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Thai women aged 25-40 years diagnosed with infertile requiring hysterosalpingography as initial investigation 2. Regular menstrual cycle with a mean length ranging between 24-38 days 3. Body mass index 18.5-24.9 kg/m2

Exclusion criteria

Exclusion criteria: 1. Polycystic ovarian syndrome diagnosed by Rotterdam criteria 2003 2. No history of adnexa surgery 3. No history of chemotherapy 4. No history of radiotherapy 5. No history of pelvic radiograph 6. No current smoking 7. No hormonal use within the last 3 months

Design outcomes

Primary

Measure	Time frame
Changes in serum antimullerian hormone level At enrollment, 1 month and 3 months Serum antimullerian hormone by ELISA generation II	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactPhawat Matemanosak

Faculty of Medicine, Prince of Songkla University

phawattm@gmail.com66897391272

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026